Clindamycin

• CAT Number: A000300
• CAS Number: 18323-44-9
• Molecular Formula: C18H33ClN2O5S
• Molecular Weight: 425.00
• Purity: 98%
• Appearance: A crystalline solid
• Storage: 3 years -20C powder
• IUPAC Name: (2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
• InChI: InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9-,10+,11-,12+,13-,14+,15+,16+,18+/m0/s1
• InChIKey: KDLRVYVGXIQJDK-AWPVFWJPSA-N
• SMILES: CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl

Clindamycin（Cat No.:A000300）is a lincosamide antibiotic effective against a wide range of gram-positive bacteria and some anaerobes. It inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, stopping bacterial growth. Often used to treat skin, respiratory, and soft tissue infections, Clindamycin is also significant in research on bacterial resistance and biofilm disruption. Its role in treating infections caused by Staphylococcus and Streptococcus species, including MRSA, makes it essential for studies focused on alternative therapies and antibiotic resistance, supporting efforts to combat persistent bacterial pathogens.